MedPath

BORTEZOMIB TARBIS 2,5 MG/ML SOLUCIÓN INYECTABLE

BORTEZOMIB TARBIS 2,5 MG/ML SOLUCIÓN INYECTABLE

Pending
Register Number

89182

Prescription Type

Uso Hospitalario

Authorization Date

Dec 5, 2023

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89182
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

BORTEZOMIBActive
Quantity: 2,3827 mg/ml
Name: BORTEZOMIB

ATC CLASSIFICATION (3)

L01X
L01XG
L01XG01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.